MNOV, RBL, ACAD, ORA, SMMU, ENY Are Seasonally Ripe To Go Down In the Next Five Weeks
October 14, 2016 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net is monitoring the Seasonality of MediciNova Inc. (NASDAQ:MNOV), SPDR S&P Russia (NYSE:RBL), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Ormat Technologies Inc. (NYSE:ORA), SUMMUS INC (DE) (NYSE:SMMU), GuggenheimCanadian Energy Income Index ETF (NYSE:ENY) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. buyins.net is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
The following stocks are expected to go Down:
Symbol Company Expected Return Odds By The Following Date MNOV MediciNova Inc. -17.72% 87.50% (7 of 8) Friday, November 11th 2016 RBL SPDR S&P Russia -3.20% 100.00% (6 of 6) Tuesday, November 22nd 2016 ACAD ACADIA Pharmaceuticals Inc. -14.14% 75.00% (9 of 12) Monday, November 14th 2016 ORA Ormat Technologies Inc. -5.78% 81.82% (9 of 11) Wednesday, November 9th 2016 SMMU SUMMUS INC (DE) -0.07% 100.00% (6 of 6) Friday, October 28th 2016 ENY GuggenheimCanadian Energy Income Index ETF -6.59% 88.89% (8 of 9) Thursday, November 24th 2016MediciNova Inc. (NASDAQ:MNOV) - MediciNova, Inc., a biopharmaceutical company, focuses on acquiring and developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. Its product candidates include MN-166 (ibudilast), an anti-inflammatory and neuroprotective agent for the treatment of neurological disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, and substance dependence; MN-221 (bedoradrine), a 2-adrenergic receptor agonist for the treatment of acute exacerbations of asthma; MN-001 (tipelukast), an orally bioavailable small molecule compound for the treatment of fibrotic diseases, such as nonalcoholic steatohepatitis and idiopathic pulmonary fibrosis; and MN-029 (denibulin), a novel tubulin binding agent for the treatment of solid tumor cancers. MediciNova, Inc. was founded in 2000 and is based in La Jolla, California..
SPDR S&P Russia (NYSE:RBL) - RBL.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) - ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. Its lead product candidate, NUPLAZID, has completed the Phase III pivotal trials for the treatment of Parkinson s disease psychosis and the Phase II trial for the treatment of schizophrenia, as well as is in Phase II study for the treatment of Alzheimer s disease psychosis. It also has clinical-stage programs for glaucoma and, in collaboration with Allergan, Inc., for chronic pain. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California..
Ormat Technologies Inc. (NYSE:ORA) - Ormat Technologies, Inc. engages in the geothermal and recovered energy power business worldwide. The company operates in two segments, Electricity and Product. The Electricity segment develops, builds, owns, and operates geothermal and recovered energy-based power plants; and sells electricity. The Product segment designs, manufactures, and sells equipment for geothermal and recovered energy-based electricity generation, including fossil fuel powered turbo-generators and heavy duty direct-current generators. It also provides services relating to the engineering, procurement, construction, operation, and maintenance of geothermal and recovered energy-based power plants. This segment serves contractors; and owners and operators of geothermal power plants, interstate natural gas pipelines, gas processing plants, and cement plants, as well as companies in other energy-intensive industrial processes. The company was founded in 1965 and is based in Reno, Nevada. Ormat Technologies, Inc. is a subsidiary of Ormat Industries Ltd..
SUMMUS INC (DE) (NYSE:SMMU) - SUMMUS INC (DE).
GuggenheimCanadian Energy Income Index ETF (NYSE:ENY) - ENERNORTH INDUSTR.
About BUYINS.NET
BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.
Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net